ÂÜÀòÂÒÂ×

Lena A. Nasser is a Director and Global Regulatory Leader at Genentech, where they currently oversee the global regulatory strategy for respiratory programs, including Ph3 and marketed products. Previously, Lena served as Program Manager in Regulatory Affairs for oncology, successfully leading sBLA submissions that garnered FDA, EMA, and Swissmedic approvals. Their career at Genentech also includes significant roles in immunology, where Lena managed US regulatory support for biologics and contributed to essential filing and submission strategies. Passionate about mentoring and team empowerment, Lena is dedicated to advancing regulatory processes and building strong collaboration.